Nimotuzumab in Treatment of Infiltrating Squamous Cell Carcinoma of Tongue

HTML  XML Download Download as PDF (Size: 526KB)  PP. 141-145  
DOI: 10.4236/jct.2015.62015    6,134 Downloads   7,160 Views  
Author(s)

ABSTRACT

A 50-year male patient presented to outpatient department with a mass on tongue associated with pain. A plain computerised tomography scan done on 17/01/13 revealed mild growth on lateral border of tongue with an enlarged jugulo-digastric lymph node measuring 1.8 × 1 cm. Excision of tongue was done and sent for histopathological examination which revealed infiltrating squamous cell carcinoma. The patient was treated with 2 cycles of Induction chemotherapy with cisplatin and paclitaxel administered in q3w schedule. Induction chemotherapy was followed by concurrent chemoradiotherapy with 6 cycles of nimotuzumab 200 mg and cisplatin 20 mg given weekly along with 60 gy/30 fractions of radiation using IMRT. Latest CT scan done on 20/01/2014 revealed no evidence of disease (NED).

Share and Cite:

Prasad, A. (2015) Nimotuzumab in Treatment of Infiltrating Squamous Cell Carcinoma of Tongue. Journal of Cancer Therapy, 6, 141-145. doi: 10.4236/jct.2015.62015.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.